A phase 3, Prospective, Multicenter, Umcontrolled, Open-label Clinical Study to Determine the Efficiacy, Safety and Tolerability of Recombinant Von Willebrand Factor (rVWF) with or without ADVATE in Children Diagnosed with Severe von Willebrand Disease | AVESİS

İstanbul Üniversitesi Akademik Veri Yönetim Sistemi

A phase 3, Prospective, Multicenter, Umcontrolled, Open-label Clinical Study to Determine the Efficiacy, Safety and Tolerability of Recombinant Von Willebrand Factor (rVWF) with or without ADVATE in Children Diagnosed with Severe von Willebrand Disease

KOÇ ŞENOL S. B.

Diğer Uluslararası Fon Programları, 2017 - Devam Ediyor

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Ocak 2017
Bitiş Tarihi: Devam Ediyor